• HTA67 Assessing Relationships Between the Canadian Agency for Drugs and Technologies in Health (CADTH) Revised ICERs and Unmet Need, Clinical Benefit, Price Reductions, and Listing Negotiation Timelines

    Jun 1, 2024, 00:00

  • MSR43 Identifying Eligibility for Chimeric Antigen Receptor T-Cell Therapy Among Diffuse Large B-Cell Lymphoma Patients Using Real-World Data and Unsupervised Machine Learning

    Jun 1, 2024, 00:00

  • CO60 A Vocation for Life on Land, Sea and Air - Health Assessment of Ambulance Workers

    Jun 1, 2024, 00:00

  • RWD26 Tokenization-Linked Social Determinants of Health (SDoH) Data: A Gateway to Enhanced Understanding of Rare Disease Clinical Trial Populations

    Jun 1, 2024, 00:00

  • HPR33 Short- and Long-Term Impacts of the National Essential Medicines Policy on Drug in Rural China

    Jun 1, 2024, 00:00

  • HTA2 A Comparison of NICE Timelines for Highly Specialised Technology Submissions and Resubmissions

    Jun 1, 2024, 00:00

  • SA4 Missingness Patterns in a Survey of Barriers to Care Among Individuals Diagnosed With Cancer: An Exploratory Analysis

    Jun 1, 2024, 00:00

  • PCR245 Patient Characteristics and Improved Outcomes With Greater Adherence to Acthar® Gel in Nephrotic Syndrome

    Jun 1, 2024, 00:00

  • EE447 Evaluating the Impact of Disease Prevalence and Product Administration on Launch Pricing Trends for Non-Oncology Orphan Products

    Jun 1, 2024, 00:00

  • MT34 The Impact of the Use of a Digital Diabetes Management Application on HCRU-Related Costs and Pharmacy Claims in Patients With Type 2 Diabetes Mellitus

    Jun 1, 2024, 00:00

  • HPR152 The Impact of Insurance Reform on Health Resource Utilization and Persistence for Chinese Patients With Crohn’s Disease, Taking Ustekinumab as an Example: Evidence From a Natural Experiment Study

    Jun 1, 2024, 00:00

  • EPH21 Burden of Unresectable/Metastatic Melanoma(u-mMel) and Advanced/Metastatic Colorectal Cancer(mCRC), and Their Associated BRAF-mutations in Four LATAM Countries: A Targeted Literature Review of Epidemiological and Economic Evidence

    Jun 1, 2024, 00:00

  • EE52 The Burden of Intravenous vs Subcutaneous Oncological Products Application in Honduras

    Jun 1, 2024, 00:00

  • EE197 The Impact of Funding Tocilizumab for the Inpatient Treatment of COVID-19 in the United States: A Distributional Cost-Effectiveness Analysis

    Jun 1, 2024, 00:00

  • CO83 Screening Articles in a Qualitative Literature Review Using Large Language Models: A Comparison of GPT Versus Open Source, Trained Models Against Expert Researcher Screening

    Jun 1, 2024, 00:00

  • CO51 Effect of Donated Plasma on Laboratory Parameters and Motivating Factors of Donated Plasma

    Jun 1, 2024, 00:00

  • HTA70 Early Patient Access to Life Saving Drugs across Europe – A Review of the Characteristics and Availability of Drugs in Early Access Programs in EU4 and the UK

    Jun 1, 2024, 00:00

  • EE163 Impact of Slowing Alzheimer’s Disease (AD) Progression: A Simulation Model in a Population of Patients with Early AD in the United States

    Jun 1, 2024, 00:00

  • EE175 Economic Burden of Pneumococcal Disease Among US Children — A Review of Cost-Effectiveness Analyses of Pneumococcal Vaccines

    Jun 1, 2024, 00:00

  • EPH233 Exploring Disparities in Prep Prescriptions for High-Risk HIV Patients Using Real-World Data

    Jun 1, 2024, 00:00

  • CO175 Quality of Life and Productivity Loss Cost Associated with Low Back Pain By Severity in Korea

    Jun 1, 2024, 00:00

  • EE9 Economic Burden of Gaucher Disease in Colombia

    Jun 1, 2024, 00:00

  • HPR14 Lessons From History: Gauging Part D Plan Access Restrictions of Protected Class Drugs as a Harbinger for Coverage of Negotiated Drugs

    Jun 1, 2024, 00:00

  • SA9 Validation of a Claims-Based Algorithm to Identify Major Congenital Malformations in Infants Using a Linked Claims-EMR Database

    Jun 1, 2024, 00:00

  • EPH17 Prevalence and Characteristics of Urinary Tract Infections in Office-Based Physician Practices in the United States, 2016–2019

    Jun 1, 2024, 00:00

  • PCR235 Study of the Dietary Habits and Quality of Life of People with Phenylketonuria

    Jun 1, 2024, 00:00

  • HSD32 Treatment Patterns and Healthcare Resource Use Among Patients With Axial Spondyloarthritis and Comorbid Inflammatory Bowel Disease

    Jun 1, 2024, 00:00

  • MSR95 Artificial Intelligence for Targeted Literature Review Screening within the Rayyan Platform

    Jun 1, 2024, 00:00

  • SA12 Investigator Choice Comparator Arms in Oncology Clinical Trials: Implications for HTA/Reimbursement Assessments

    Jun 1, 2024, 00:00

  • CO152 Glycemic Control and Long-Term Macrovascular Outcomes in People With Type 2 Diabetes in China: A Retrospective Study

    Jun 1, 2024, 00:00

  • Do Quality-Adjusted Life Years Discriminate Against the Elderly? An Empirical Analysis of Published Cost-Effectiveness Analyses [Editor's Choice]

    Jun 1, 2024, 00:00

  • EPH66 Pre-Exposure Prophylaxis Adherence Trajectories and HIV and Sexually Transmitted Infections Risk

    Jun 1, 2024, 00:00

  • EE74 Economic Burden and Healthcare Resource Utilization in Patients with Systemic Lupus Erythematosus (SLE): A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • HPR1 Prescription Nutraceutical Clinical Evidence Requirements in the Treatment of Depression: Comparing US and EU Guidance for Phase II and III Clinical Trials

    Jun 1, 2024, 00:00

  • HTA4 Criteria for Decision Making in Health Economic Evaluations: An Analysis of Global Practices

    Jun 1, 2024, 00:00

  • EE473 Health Care Resource Use in the Management of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Canada

    Jun 1, 2024, 00:00

  • RWD94 Targeting a Modifiable Risk Factor: A Causal Framework Informs Strategies to Reduce Pressure Injuries

    Jun 1, 2024, 00:00

  • RWD133 Postoperative Outcomes of Patients Undergoing Rotator Cuff Repair With Osteoporosis: A TriNetX Database Study

    Jun 1, 2024, 00:00

  • PCR190 Food Insecurity As a Determinant of Poorer Health-Related Quality of Life Among Patients with Chronic Conditions in the United States

    Jun 1, 2024, 00:00

  • HSD62 Real-World Treatment Patterns in the Metastatic Hormone-Sensitive Prostate Cancer Setting Across Europe

    Jun 1, 2024, 00:00

  • RWD83 Real-World Treatment Patterns in Adults With Chronic Inflammatory Demyelinating Polyneuropathy in the United States

    Jun 1, 2024, 00:00

  • HPR84 Variation in Commercial Coverage of Accelerated Approval Drugs

    Jun 1, 2024, 00:00

  • PT24 Quality Appraisal of Randomized Controlled Trials Using Robins 2.0 Tool: A Case Study on Comparing the Performance of ChatGPTv4.0 With a Human Reviewer

    Jun 1, 2024, 00:00

  • EE285 Economic Burden of Gestational Diabetes: A Global Targeted Literature Review

    Jun 1, 2024, 00:00

  • EE54 A Framework for Evaluating the Economic Impact of Artificial Intelligence for Screening Mammography: Implications for Facilities and Payers from the US Perspective

    Jun 1, 2024, 00:00

  • The Value of the Quality-Adjusted Life Years

    Jun 1, 2024, 00:00

  • CO166 Patient Reported Outcomes of Vonoprazan in Chinese Reflux Esophagitis Patients: A Prospective Real-World Study

    Jun 1, 2024, 00:00

  • HSD100 Effectiveness of Data-to-Care Proactive Adherence Interventions on Retention and Relinkage to HIV Care Amid COVID Pandemic

    Jun 1, 2024, 00:00

  • HSD37 Prescribing Trends of Newly Approved Sickle Cell Disease-Modifying Medications

    Jun 1, 2024, 00:00

  • EE6 Healthcare Resource Utilization and Costs Associated With a Peptide-Based Enteral Formula With Fruit and Vegetable Ingredients: Retrospective Analysis of Children and Adults in Post-Acute Care

    Jun 1, 2024, 00:00

  • EE338 NICE Reconsideration for Oncology Drugs Based on Single-Arm Trials Referred to Cancer Drug Fund

    Jun 1, 2024, 00:00

  • RWD140 Obeticholic Acid for Primary Biliary Cholangitis: Modeling Prevention of Clinical Events Using Real-World Data

    Jun 1, 2024, 00:00

  • EE404 A Cost-Effectiveness Analysis of a Triple-Agent Topical Fixed-Dose Combination of 1.2% Clindamycin Phosphate, 0.15% Adapalene, and 3.1% Benzoyl Peroxide Gel for the Treatment of Moderate-to-Severe Acne Vulgaris in the United States

    Jun 1, 2024, 00:00

  • HSD13 Missed Opportunities for Respiratory Disease Diagnosis in the United States During Endemic Spread of SARS-CoV-2

    Jun 1, 2024, 00:00

  • EPH12 A Retrospective Natural History Study of Incident Adult Dermatomyositis and Polymyositis Patients Using Real World Data

    Jun 1, 2024, 00:00

  • EE446 Economic Burden of Mild or Moderate Asthma in Pediatric Patients from the Perspective of Public Health Institutions in Mexico

    Jun 1, 2024, 00:00

  • EE102 Estimate Broader Economic Impact of Lecanemab for Medicare Beneficiaries Alzheimer's Disease Patients: Budget Impact and Input-Output Models

    Jun 1, 2024, 00:00

  • EE290 Targeted Literature Review of Cost-Effectiveness Models in Relapsed/Refractory Follicular Lymphoma

    Jun 1, 2024, 00:00

  • EE73 Direct Healthcare Costs Associated With Primary Symptomatic Cytomegalovirus in the United States

    Jun 1, 2024, 00:00

  • EE177 The Cost-Effectiveness Analysis of Anaprazole Versus Ilaprazole for Treating Duodenal Ulcers in China

    Jun 1, 2024, 00:00

  • P62 Targeted Literature Review of the Use of Real-World Evidence From Single Real-World Data Sources and in Meta-Analyses: Methodologies and Recommendations From Health Technology Assessment Bodies

    Jun 1, 2024, 00:00

  • CO82 Bayesian Pan-Tumor Multilevel Meta-Regression: An Unanchored Indirect Treatment Comparison (ITC) of Adagrasib Versus Sotorasib in Previously Treated KRASG12C-mutated Advanced/Metastatic Solid Tumors

    Jun 1, 2024, 00:00

  • EPH93 Trends and Regional Variation in New Opioid Prescriptions and Long-Term Prescription Opioid Use Among Older Adults in the United States, 2012-2020

    Jun 1, 2024, 00:00

  • HTA44 Systematic Literature Review Requirements for Health Technology Assessment in European Markets

    Jun 1, 2024, 00:00

  • MT19 A High-Quality, Low-Cost Patient Care Model: Barcode-Based Counseling

    Jun 1, 2024, 00:00

  • CO58 Disease- and Glucocorticoid-Related Comorbidities in Classic Congenital Adrenal Hyperplasia: A Claims-Based Retrospective Cohort Analysis

    Jun 1, 2024, 00:00

  • EE314 Costs of Transcatheter Versus Surgical Aortic Valve Replacement in Brazil

    Jun 1, 2024, 00:00

  • EPH92 A Targeted Literature Review on Medication Adheren A Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) Study

    Jun 1, 2024, 00:00

  • HSD25 Patients’ Rare Disease Diagnoses and Their Impact on Physicians’ Emotions: A Cross-Sectional Study in the United States

    Jun 1, 2024, 00:00

  • EE88 Cost-Effectiveness of Apixaban Compared to Warfarin, Dabigatran and Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation: Results for High-Risk Patient Subgroups Based on the Aristophanes Real-World Evidence Study

    Jun 1, 2024, 00:00

  • MSR10 Cardiovascular Events Prediction on a Synthetic Cohort in Low-Income Setting with Machine Learning

    Jun 1, 2024, 00:00

  • HPR51 Use of Real World Evidence in 2023 Novel Drug Approvals

    Jun 1, 2024, 00:00

  • EE310 The Burden of Blood Transfusions Associated With Lower-Risk Myelodysplastic Syndromes (LR-MDS): Findings From a Survey of Health Care Professionals (HCPs) in Brazil, Germany, and Japan

    Jun 1, 2024, 00:00

  • HTA38 What Is the Value of Reducing the Use of Scarce Biological Resources Such As Donor Organs?

    Jun 1, 2024, 00:00

  • P11 Beyond Accuracy: Fairness Implications in High-Cost User Prediction Models Among Incident Lung Cancer Survivors

    Jun 1, 2024, 00:00

  • EPH5 COVID-19 Vaccine Acceptance Disparities Among Foreign-Born and US-Born Individuals in California: A 2021 Cross-Sectional Analysis

    Jun 1, 2024, 00:00

  • CO27 Survival and Cost of Care By Type of First-Line Therapy in Metastatic Non-Small Lung Cancer Using SEER-Medicare Data

    Jun 1, 2024, 00:00

  • EE364 Cost-Effectiveness of Artificial-Intelligence Enabled Kidney Disease Risk Stratification in US Veterans With Early-Stage Diabetic Kidney Disease

    Jun 1, 2024, 00:00

  • CO134 Association between Baseline Lung Function and Oral Corticosteroid Elimination in Patients with Oral Corticosteroid-Dependent Severe Asthma

    Jun 1, 2024, 00:00

  • HSD26 Descriptive Landscape for Precision Medicines in Second-Line Biliary Tract Cancer: A Targeted Literature Review

    Jun 1, 2024, 00:00

  • MSR86 Leveraging Large Language Models for Efficient Observational Research Protocol Drafting: Insights and Best Practices for Openllama

    Jun 1, 2024, 00:00

  • PCR112 Exploring Rare Disease Landscape Using Social Media Listening to Assess Patient Voices

    Jun 1, 2024, 00:00

  • RWD62 Enriching the Value of Real-World Oncology Data With Important Clinical Information From Unstructured Data Sources for Better Clinical Insight Generation

    Jun 1, 2024, 00:00

  • EE186 Trends in Cost of Treatment with Immuno-oncology Drugs in the US

    Jun 1, 2024, 00:00

  • P23 Validity of the EQ-HWB-S in United States-Based Caregivers

    Jun 1, 2024, 00:00

  • CO43 A Systematic Literature Review of Comparative Efficacy Measures in Randomized Controlled Trials of Darolutamide Treatment in Metastatic Hormone-Sensitive Prostate Cancer

    Jun 1, 2024, 00:00

  • HPR92 Assessment of Surrogate Endpoints in Real-World Oncology Studies, a Systematic Literature Review

    Jun 1, 2024, 00:00

  • HTA73 Cured and Invisible? Rationale for Mixture-Cure Models As Base-Case for HTA in Diffuse-Large B-Cell Lymphoma (DLBCL)

    Jun 1, 2024, 00:00

  • HPR15 Comparison of Price Index Methods and Drug Price Inflation Estimates for Medications for Opioid Use Disorder (MOUD)

    Jun 1, 2024, 00:00

  • HPR52 Disparity in New Cancer Drug Launches Worldwide: 1990-2022

    Jun 1, 2024, 00:00

  • HPR116 Do US Managed Care Organizations Restrict Coverage More Than the Food and Drug Administration Label?

    Jun 1, 2024, 00:00

  • HPR145 Anti-VEGF Molecule Utilization in Ophthalmology and Potential Impact of Market Dynamics after Biosimilar Entry

    Jun 1, 2024, 00:00

  • RWD128 Herpes Zoster Infection in Adults With Rheumatic Diseases in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • PCR18 Systematic Literature Review of Health Utility Values in Adult Patients with Post-Traumatic Stress Disorder

    Jun 1, 2024, 00:00

  • OP17 Are Dengue-Related Technological Solutions Evolving to Address the Global Public Health Problem?

    Jun 1, 2024, 00:00

  • EE254 The Cost-Consequence of Budesonide/Formoterol Plus As-Needed Saba As Treatment for 6-12 Years Old Pediatric Asthma Patients in ChinaBased on Real-World Data

    Jun 1, 2024, 00:00

  • CO103 Antidepressant Adherence Using Group-Based Trajectory Modeling Among Postpartum Women With Texas Medicaid

    Jun 1, 2024, 00:00

  • EPH65 Burden of Illness of Osteogenesis Imperfecta in Ontario, Canada

    Jun 1, 2024, 00:00

  • MSR80 Estimands and Strategies for Handling Treatment Switching As an Intercurrent Event in Evidence Synthesis of Randomized Clinical Trials in Oncology

    Jun 1, 2024, 00:00

  • RWD153 Best of Both Worlds: Enhancing Claims Data with Lab Results in Real-World Evidence Generation

    Jun 1, 2024, 00:00

  • EE1 Comparative Cost-Effectiveness Analysis of Interventions for Perinatal Methamphetamine Use Disorder: A Decision Modeling Method

    Jun 1, 2024, 00:00

  • P35 Are Proposals for a Scheme to Stimulate Investment in Critically Needed New Antimicrobials Fit for Purpose?

    Jun 1, 2024, 00:00

  • EE176 Economic Burden and Healthcare Resource Utilization in Patients with Psoriatic Arthritis (PsA): A Systematic Literature Review

    Jun 1, 2024, 00:00

  • MSR91 Assessing Recall in Abstract Screening: Artificial Intelligence Vs. Human Reviewers

    Jun 1, 2024, 00:00

  • PCR257 Beliefs and Factors Associated With Intentions to Initiate Antihypertensive Medications

    Jun 1, 2024, 00:00

  • HPR78 Eliciting Inequality Aversion in the United States: Results from a Benefit Trade-Off Experiment

    Jun 1, 2024, 00:00

  • RWD29 Predictive Model for Dementia in Patients with Type 2 Diabetes Using a Common Data Model

    Jun 1, 2024, 00:00

  • EE365 Empowering Access: Evaluating the Impact of Partnerships for Productive Development (PDP) on Access to Rituximab in Brazil

    Jun 1, 2024, 00:00

  • SA25 Diagnostic Test Accuracy of Serum Amylase and Lipase for Diagnosing Acute Pancreatitis: A Meta-Analysis

    Jun 1, 2024, 00:00

  • EPH48 Would Exposure to Metformin Reduce Mortality in Patients With Glioblastioma?

    Jun 1, 2024, 00:00

  • EPH105 Obesity Continues to be Associated With Poor Health-Related Quality of Life During the Third Year of the COVID-19 Pandemic

    Jun 1, 2024, 00:00

  • CO85 Longitudinal Patterns of Loss of Independence in Parkinson Disease

    Jun 1, 2024, 00:00

  • EE83 Total Costs and Cost Savings of Comprehensive Knee Osteoarthritis Management Combined With Total Knee Arthroplasty in an Ambulatory Surgical Center

    Jun 1, 2024, 00:00

  • EE103 Cost-Effectiveness of Universal Newborn Screening for Spinal Muscular Atrophy With Disease-Modifying Therapies in Taiwan

    Jun 1, 2024, 00:00

  • EE434 Benefits of a Polymer Tip in Torsional Phacoemulsification: A Targeted Literature Search and Budget Impact Model

    Jun 1, 2024, 00:00

  • PCR74 Health Expectations and Costs of People with Autism and Their Families

    Jun 1, 2024, 00:00

  • RWD71 The Burden of Haemophilia in 5 European Countries: Methods and Results from the Cost of Haemophilia in Europe: A Socioeconomic Survey (CHESS) 2022

    Jun 1, 2024, 00:00

  • EE174 Assessing the Cost-Effectiveness of an mRNA-Based Rsv Vaccine (mRNA-1345) Amongst Canadian Adults Aged ≥60 Years

    Jun 1, 2024, 00:00

  • PCR174 Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review

    Jun 1, 2024, 00:00

  • HSD11 Treatment Patterns and Healthcare Resource Utilization in Colombian Migraine Patients from 2018 to 2022

    Jun 1, 2024, 00:00

  • EE5 Healthcare Costs Among Commercially-Insured Patients with Hereditary Angioedema Managed with Long-Term Prophylaxis: A Retrospective US Claims Database

    Jun 1, 2024, 00:00

  • HSD78 Prescribing Patterns of Novel Oral Therapies for Ulcerative Colitis in a Large Integrated Delivery Network

    Jun 1, 2024, 00:00

  • EE383 Cost-Utility Analysis of Adapted Problem Adaptation Therapy for Depression in Mild to Moderate Dementia Caused by Alzheimer's Disease: Pathfinder Randomized Controlled Trial

    Jun 1, 2024, 00:00

  • SA57 A Comprehensive Search Filter to Identify Randomized Controlled Trials

    Jun 1, 2024, 00:00

  • HPR103 Calcimimetic Prescriptions Following the Transitional Drug Add-on Payment Adjustment in Fee-for-Service Medicare Patients on Dialysis

    Jun 1, 2024, 00:00

  • PCR143 Diagnostic Delay of Multiple Sclerosis in China: A Nationwide Cross-Sectional Study

    Jun 1, 2024, 00:00

  • PCR182 A Triangulation Approach to Develop a Conceptual Framework for the Patient-Reported Outcome Measures across the Life Cycle: A Case of Patients with X-Linked Hypophosphatemia

    Jun 1, 2024, 00:00

  • EE504 Cost-Effectiveness Analysis of Tremelimumab As First-Line Therapy for Metastatic Non-Small Cell Lung Cancer in Japan

    Jun 1, 2024, 00:00

  • EE97 Micro-Costing of Relapse and Refractory EGPA Treatment in Brazil Using the Lens of Experts

    Jun 1, 2024, 00:00

  • RWD185 Prediction of Disease Severity Using Machine Learning Algorithms: An Analysis for Chronic Kidney Disease in the US

    Jun 1, 2024, 00:00

  • HSD117 Causes and Characteristics of Drug Shortages in the United States

    Jun 1, 2024, 00:00

  • EE302 Cost-Utility Analysis of Eptinezumab Versus Erenumab for Episodic Migraine Headaches Patients in the United States

    Jun 1, 2024, 00:00

  • EE145 The Economic Impact of Overweight and Obesity-Related Diseases in Colombia

    Jun 1, 2024, 00:00

  • PCR237 Assessing the Presence of Anxiety and Depression Among Pregnant Women

    Jun 1, 2024, 00:00

  • PCR43 Health Utility Decrement of Injection Treatment-Related Attributes Among Type 2 Diabetes Patients in China

    Jun 1, 2024, 00:00

  • EE120 Economic Burden of Pompe Disease in Colombia

    Jun 1, 2024, 00:00

  • CO102 The Importance of Potassium Ion Disturbances in Emergency Care

    Jun 1, 2024, 00:00

  • HPR68 How Will the New VPAG Rebate Regulations Affect Launch Strategy in the UK?

    Jun 1, 2024, 00:00

  • EPH227 Identifying Prediabetes Patients Using Administrative Claims Linked with Lab Data to Assess Progression to Type 2 Diabetes

    Jun 1, 2024, 00:00

  • CO49 Progression of Chronic Kidney Disease Among Older Adults with Hypertension Using Group-Based Trajectory Modeling

    Jun 1, 2024, 00:00

  • EPH215 Recent Trends in the Incidence and Prevalence of Atopic Dermatitis in the United States: Eliciting Differences by Age and Sex

    Jun 1, 2024, 00:00

  • PCR220 Enhancing Non-Experts' Understanding of Uncertainty in Psychometric Results through Effective Visual Probabilistic Representations

    Jun 1, 2024, 00:00

  • P51 Characterization of Misdiagnosed Opsoclonus Myoclonus Ataxia Syndrome (OMAS)

    Jun 1, 2024, 00:00

  • MSR19 Methods for Relaxing the Proportional Odds Assumption in Meta-Analysis of Aggregate Data

    Jun 1, 2024, 00:00

  • EE486 Impact of COVID-19 Pandemic on IV Iron (IVI) Cost and Utilization in Commercially-Insured Patients With Iron Deficiency Anemia (IDA)

    Jun 1, 2024, 00:00

  • CO56 Evaluation of Real-World Treatment Outcomes Among Women 50 Years of Age and Older Who Were Treated With Statin + Ezetimibe or Statin Monotherapy in Italy and Belgium

    Jun 1, 2024, 00:00

  • Perspectives on Improving Value Assessment With the ISPOR SUITABILITY Checklist [Editor's Choice]

    Jun 1, 2024, 00:00

  • CO74 Hospitalizations with Initiation of Hydroxychloroquine in Patients with Heart Failure with Preserved Ejection Fraction and Autoimmune Disease

    Jun 1, 2024, 00:00

  • CO44 Exploring the Impact of Non-Steroidal Immunosuppressive Drugs and Steroids on the Development of Comorbidities in Patients With Myasthenia Gravis in the National Veterans Affairs Health Network

    Jun 1, 2024, 00:00

  • PCR12 Exploring Patterns of Treatment Utilization and Promis Scores in a Home-Reported Outcomes Study for Individuals with Sickle Cell Disease (SCD)

    Jun 1, 2024, 00:00

  • RWD75 Machine Learning in Healthcare: Analyzing Cost Prediction Biases to Ensure Health Equity Among Older Adults With Incident Hodgkin’s Lymphoma

    Jun 1, 2024, 00:00

  • HSD88 The Impact of Diagnosing Provider Type on Longitudinal Care for Patients With Newly Diagnosed Huntington’s Disease (HD)

    Jun 1, 2024, 00:00

  • EE100 Exploring Frameworks and Methodologies to Incorporate Equity in Health Economics Evaluation: A Scoping Review

    Jun 1, 2024, 00:00

  • PCR9 Role of Video Versus Text Information in Willingness to be Vaccinated for Invasive Meningococcal Disease Among US Adolescents/Young Adults and Parents

    Jun 1, 2024, 00:00

  • EE523 Costs Per Responder With Venetoclax in Combination With Azacitidine in Unfit Patients With Previously Untreated Acute Myeloid Leukemia in China

    Jun 1, 2024, 00:00

  • CO64 Prevalence of Immunosuppressants and Antifibrotic Use in Patients With Connective Tissue Disease-Related Interstitial Lung Disease

    Jun 1, 2024, 00:00

  • EE395 Cost-Effectiveness Analysis of Nivolumab Plus Relatlimab (NIVO+RELA) Versus Current Standard of Care (SOC) for Patients with Unresectable or Metastatic Melanoma in Canada

    Jun 1, 2024, 00:00

  • CO75 Clinical Outcomes Associated with Anti-CD38 Retreatment in Relapsed/Refractory Multiple Myeloma: A Review of the Literature

    Jun 1, 2024, 00:00

  • EE481 Long-Term Cost-Effectiveness of Tirzepatide Versus Placebo for Individuals With Type 2 Diabetes and Obesity

    Jun 1, 2024, 00:00

  • OP12 Exploring Preferences in Selecting Dissertation Topics Among Ph.D. Students in Health Economics and Outcomes Research (HEOR) in the United States

    Jun 1, 2024, 00:00

  • EPH79 HPV-Associated Cancers in Men: Epidemiological and Economic Burden in Costa Rica

    Jun 1, 2024, 00:00

  • PCR42 Health State Utilities in Duchenne Muscular Dystrophy (DMD): A Longitudinal Study Using the EQ5D and Health Utilities Index (HUI)

    Jun 1, 2024, 00:00

  • Patient-Centered Research

    Jun 1, 2024, 00:00

  • EE32 Determining the Expected Pricing Advantage of First-in-Indication and First-in-Class Non-Oncology Orphan Products

    Jun 1, 2024, 00:00

  • EE95 Value Comparison of BACT/ALERT®; VIRTUO® System Versus BD BACTEC™ FX Blood Culture System from a Provider Perspective

    Jun 1, 2024, 00:00

  • EPH82 Risk Perception of Tobacco and Nicotine Products: Which Consumer Reported Outcome Measures for Evidence Generation in Support of Regulatory Engagement?

    Jun 1, 2024, 00:00

  • PCR259 No Value Without Equity: Transforming Power, People and Process for Equity in Health Technology Assessment

    Jun 1, 2024, 00:00

  • Patient-Centered Research

    Jun 1, 2024, 00:00

  • EE380 Exploring the Impact of a Rare Disease (RD) Diagnosis on Work Productivity and Social Activity Impairment: A Systematic Literature Review (SLR) across Six Disease Areas

    Jun 1, 2024, 00:00

  • HTA36 ATMP Reimbursement: A Targeted Review of Global HTA Assessment Trends

    Jun 1, 2024, 00:00

  • HTA21 Organizations Responsible for the Evaluation of Health Technologies Globally: A Scoping Review

    Jun 1, 2024, 00:00

  • HPR9 Racial and Ethnic Inequities in Endometrial Cancer Survival From 2017 to 2022: Assessing the Influence of Social Determinants of Health

    Jun 1, 2024, 00:00

  • MSR49 Long-Term Survival Prediction in Early Breast Cancer: A Machine Learning Approach With Random Survival Forest

    Jun 1, 2024, 00:00

  • HPR106 Pricing of New Oncology Products in the US and Key European Markets

    Jun 1, 2024, 00:00

  • EPH223 Excess of Mortality By Asthma during COVID-19 Pandemic in Colombia

    Jun 1, 2024, 00:00

  • MT5 Comparison of Outcomes of ePTFE Vascular Grafts With Heparin End-Point Covalent Bond and Alternative Autologous Vein for Below-Knee Surgical Bypass Procedures in Critical Limb Ischemia Patients

    Jun 1, 2024, 00:00

  • PCR73 Health Care for People with Autism in the COVID-19 Pandemic

    Jun 1, 2024, 00:00

  • EE134 Budget Impact Analysis of Machine Learning Models for Diagnosing Alzheimer's Dementia

    Jun 1, 2024, 00:00

  • EE421 Integrating Payer Reimbursement Strategies Into Modeling and Simulation (MS)-Based Methods to Redefine Drug Development

    Jun 1, 2024, 00:00

  • EE10 The Impact of Spinal Muscular Atrophy Type 1 (SMA1) on Caregivers in Brazil: Results of a Global Survey

    Jun 1, 2024, 00:00

  • MT12 Economic Outcomes of Polarstem Stem, R3 Acetabular Shell and Oxidized Zirconium Femoral Heads (POLAR3) Vs Non-POLAR3 Implant System in Total Hip Arthroplasty: A Real World Evidence Analysis

    Jun 1, 2024, 00:00

  • EE409 An Applicable Method to Estimate the Broader Value of Antibiotics: Dynamic Transmission Model

    Jun 1, 2024, 00:00

  • EE146 Comparative Analysis of the Burden of Illness Among Juvenile Idiopathic Inflammatory Myopathy Versus Juvenile Idiopathic Arthritis in the United States

    Jun 1, 2024, 00:00

  • EE331 Clinical and Health Outcomes Associated With Different Treatment Sequences for Moderate-to-Severe Ulcerative Colitis

    Jun 1, 2024, 00:00

  • HTA48 Systematic Review and Quality Assessment of Clinical and Economic Evidence For Superabsorbent Wound Dressings in a Population with Chronic Ulcers

    Jun 1, 2024, 00:00

  • RWD131 Replicating Published Real-World Evidence Studies Using Electronic Medical Records From Community Hospitals

    Jun 1, 2024, 00:00

  • MSR79 Evaluation of Real-World Response Rate in Clinical Trial-Aligned Cohorts of Patients With Lung, Colon, and Breast Cancer Using Machine Learning

    Jun 1, 2024, 00:00

  • HPR31 A Targeted Literature Review To Identify the Dimensions of Sustainable Global Biosimilars Markets

    Jun 1, 2024, 00:00

  • PCR88 Overall Retention and Characteristics Associated With Longitudinal Completion of Remote Patient-Reported Outcome Questionnaires in a Representative, General Population Cohort Study: The Project Baseline Health Study

    Jun 1, 2024, 00:00

  • PCR150 Burden of Invasive Meningococcal Disease in Survivors and Their Caregivers in the United States: A Cross-Sectional Non-Interventional Mixed Methods Study

    Jun 1, 2024, 00:00

  • MSR85 Efficacy of Modern Oral Antidiabetic Drugs: A Systematic Literature Review Network Meta-Analysis

    Jun 1, 2024, 00:00

  • HPR85 Estimating the Income Elasticity of Abortion: A Cross-National Study of 99 Countries

    Jun 1, 2024, 00:00

  • EE137 Economic Burden for Adults With Sickle Cell Disease and Matched Controls in the United States: Retrospective Analysis of a Commercial Insurance Database

    Jun 1, 2024, 00:00

  • SA21 Economic Analysis of Germline Genetic Testing to Assess for Hereditary Colorectal Cancer: A Systematic Review

    Jun 1, 2024, 00:00

  • EE178 Evaluating the Budget Impact of Introducing Preventive Therapy in the Preclinical Phase for Rheumatoid Arthritis : A Focus on Algerian Female Population at Risk

    Jun 1, 2024, 00:00

  • HTA58 HTA Assessment of Single-Arm Trials: Comparison between the HAS and SMC

    Jun 1, 2024, 00:00

  • P63 Comparative Analysis of Health Technology Assessment Agency Frameworks for Digital Health Technologies

    Jun 1, 2024, 00:00

  • RWD173 Using Population Data to Develop Precision Based Approaches to Hepatits C Prevention

    Jun 1, 2024, 00:00

  • PCR37 Differences in PHQ-9 Scores Based on Remote Digital Versus in-Person Administration: Findings From the Project Baseline Health Study

    Jun 1, 2024, 00:00

  • EPH228 Disability and Workers’ Compensation Absences Associated With Major Depressive Disorder and the Overlap With Family Medical Leaves Among United States Employees

    Jun 1, 2024, 00:00

  • EE169 Cost to Achieve Seizures Reduction or Seizure Freedom in Dravet Syndrome in the USA: An Analysis Based on NNT (NUMBER NEEDED TO TREAT) of Stiripentol, Fenfluramine and Cannabidiol

    Jun 1, 2024, 00:00

  • HTA74 Better Late Than Never? Payer Appetite and Vision for a National Value Assessment Body

    Jun 1, 2024, 00:00

  • RWD45 Inequalities in the Costs and Affordability of a Healthy Diet in Europe between 2017 and 2021

    Jun 1, 2024, 00:00

  • CO78 Transfusion Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Transfusion-Dependent Beta-Thalassemia: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • EPH83 Mortality Rate By Tuberculosis in Colombia, 2012-2021: Regional Inequalities

    Jun 1, 2024, 00:00

  • EE381 Comparative Analysis of Patient Outcomes and Hospital Costs: Robotic-Assisted Surgery Versus Conventional Laparoscopic Surgery Across Five Procedures

    Jun 1, 2024, 00:00

  • EE379 Assessing Trends in the Distribution of Prescription Claim Payments (2011-2021) and Implications for Retail Pharmacies

    Jun 1, 2024, 00:00

  • RWD130 European Health Data Space (EHDS) Requires Secure Processing Environments (SPEs) – Comparison of SPESiOR to Other SPE-Type Environments from Finnish, Nordic, European, and Global Settings

    Jun 1, 2024, 00:00

  • EPH104 Public Health Impact of Pediatric BNT162b2 XBB1.5-Adapted COVID-19 Vaccine in the United States

    Jun 1, 2024, 00:00

  • HSD102 Job Preferences of Caregivers in Integrated Medical and Nursing Care Facilities: A Discrete Choice Experiment

    Jun 1, 2024, 00:00

  • PCR224 Development and Validation of a Tool to Predict Short Term Opioid Overdose Risk after Acquiring a Prescribed Controlled Substance

    Jun 1, 2024, 00:00

  • P42 Budget Impact Analysis of Eculizumab Biosimilar for Treatment of Paroxysmal Nocturnal Hemoglobinuria from Public Hospital Perspective in 2023

    Jun 1, 2024, 00:00

  • HSD5 Real-World Treatment Patterns in Adults with Pemphigus Foliaceus in the United States

    Jun 1, 2024, 00:00

  • EPH179 Patterns of Glucocorticoid Use Among Persons with Systemic Lupus Erythematosus (SLE) over Fifteen Years

    Jun 1, 2024, 00:00

  • RWD142 A Retrospective Analysis of Impact of Triptans and CGRP on Monthly Migraine Days (MMD) in Migraine Patients in the USA

    Jun 1, 2024, 00:00

  • RWD103 Treatment Patterns and Healthcare Resource Utilization Following Initiation of Aripiprazole Lauroxil Using a 1-Day Initiation Regimen

    Jun 1, 2024, 00:00

  • EE239 Predictive Cost-Effectiveness Evaluation of Using a Machine Learning-Based Alzheimer’s Disease Risk Prediction Tool for Users of Social and Health Services Aged over 65 in Finland

    Jun 1, 2024, 00:00

  • RWD92 Contemporary Trends in Treatment Intensification for Men With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in 5 European Countries: Results From Patient Chart Reviews

    Jun 1, 2024, 00:00

  • EPH208 Prevalence and Average Annual Percent Change of Potentially Inappropriate Medication Use in Older Adults before and during the COVID-19 National Emergency

    Jun 1, 2024, 00:00

  • HTA15 European Health Technology Assessment: Historical Success of European Joint Assessments

    Jun 1, 2024, 00:00

  • PCR16 Clinical Actions Generated By Remote Symptom Alerts and Electronic Patient-Reported Outcomes (ePROs) in Real-World Breast Cancer Practice

    Jun 1, 2024, 00:00

  • MT3 US Payer Management of Digital Health Technologies: Recent Updates and a Glimpse into the Future

    Jun 1, 2024, 00:00

  • HSD72 Baseline A1C and BMI Trends for People with Type 2 Diabetes Receiving First-Time GLP-1 Ra Prescriptions

    Jun 1, 2024, 00:00

  • MSR26 Exploring the Validity of Non-Responders As a Surrogate for Treatment Comparator Survival Outcomes in the Context of Histology Independent Therapies

    Jun 1, 2024, 00:00

  • CO29 Bruton's Tyrosine Kinase Inhibitors in B-Cell Lymphoma and Risk of Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Jun 1, 2024, 00:00

  • PCR232 Do QALYs Discriminate Against the Elderly?

    Jun 1, 2024, 00:00

  • PCR261 Adherence to Endocrine Therapies Among Women With Non-Metastatic Breast Cancer in Developing Countries

    Jun 1, 2024, 00:00

  • HPR95 Why It Is Important to Ensure the Price Is Right: Access Restrictions for Therapies Treating Duchenne Muscular Dystrophy

    Jun 1, 2024, 00:00

  • MSR70 Acceptance of Artificial Intelligence Augmented Systematic Reviews by Health Technology Assessment Bodies

    Jun 1, 2024, 00:00

  • RWD19 Prescription and Reimbursement Patterns of Apixaban Post Launch: Inquiry into US Closed Claims Data for Association with Disease Severity

    Jun 1, 2024, 00:00

  • MT31 The Role of Parental Self-Efficacy, Capability Well-Being and Electronic Health Literacy in Pediatric Diabetes Management: Insights from a Longitudinal Analysis of Glucose Sensor Data

    Jun 1, 2024, 00:00

  • EE89 The Economic Impact of Anti-Scorpion Serum in the Management of Scorpion Envenomation in Algeria

    Jun 1, 2024, 00:00

  • PCR113 Patients’ Perspectives on Bleeding, Bruising, and Other Key Changes Associated With Antithrombotic Treatment

    Jun 1, 2024, 00:00

  • OP5 Drug Launches Reflect Overall Company Performan Analysis Uncovers Lessons That Large Pharmaceutical Companies Could Glean from Their Smaller Rivals’ Drug Launch Strategies

    Jun 1, 2024, 00:00

  • EE167 Cost-Effectiveness Evaluations of CAR-T Cell Therapies By Health Technology Assessment Agencies

    Jun 1, 2024, 00:00

  • PCR157 Assessment of Patient Reported Outcomes in Chronic Versus Acute Disease: A Comparison of Study Design and Analytic Approaches

    Jun 1, 2024, 00:00

  • RWD65 Characteristics of Real-World Databases in the United States: A Systematic Review

    Jun 1, 2024, 00:00

  • PCR27 Discrete Choice Experiment (DCE) Methodology Associated With a Multi-Phase Patient/Caregiver Preference Study in Growth Hormone Deficiency (GHD)

    Jun 1, 2024, 00:00

  • P34 National Costs of Prescription Drug Market Exclusivity Extensions

    Jun 1, 2024, 00:00

  • EE375 Cost Savings and the Opportunity for Expanded Treatment Access with Increased Use of Biosimilar Adalimumab in the United States

    Jun 1, 2024, 00:00

  • P52 Burden of the Untreated Attacks and Its Impact on Social, Mental and Physical Health

    Jun 1, 2024, 00:00

  • PCR155 Health-Related Quality of Life Among High School Students with Myopia in China

    Jun 1, 2024, 00:00

  • PCR170 Mental Health Status, Symptoms and Sleep Quality of Patients Hospitalized for Infection with COVID-19

    Jun 1, 2024, 00:00

  • PT42 A Systematic Literature Review and Meta-Analysis Comparing Robotic-Assisted Surgery Using the Da Vinci Surgical Systems for Benign Gynecological Procedures to Laparoscopic or Open Approach

    Jun 1, 2024, 00:00

  • PCR22 Assessing the Implementation of the "Baby-Friendly Hospital Initiative” in Hungary

    Jun 1, 2024, 00:00

  • EE291 Schizophrenia and Bipolar Disorder Burden and Economic Burden Under an Impact Analysis by Therapeutic Scheme

    Jun 1, 2024, 00:00

  • RWD179 Resource Utilization and Direct Costs of Diabetes in Relation to Heart Failure Status in Private Payer Perspective in Brazil

    Jun 1, 2024, 00:00

  • MT9 Association of Neighborhood Disparity on Access to Tissue Surgical Heart Valves

    Jun 1, 2024, 00:00

  • PCR54 Monitoring Health-Related Quality of Life Following Dietary Supplementation With Folic Acid, Vitamin B12, and Vitamin D3 in Patients Diagnosed With Parkinson Disease in Romania

    Jun 1, 2024, 00:00

  • EPH103 Fatal Outcomes from Drug Interactions: Insights from the FDA Adverse Event Reporting System

    Jun 1, 2024, 00:00

  • Disclaimer

    Jun 1, 2024, 00:00

  • P39 Quantifying Patient Preferences and Healthy-Time-Equivalents for Eosinophilic Esophagitis Treatments: A Stated-Preference Study

    Jun 1, 2024, 00:00

  • RWD1 To Investigate Gender and Racial Disparities in the Resource Utilization of Patients With Lung Diseases in the US: A Real-World Data Study

    Jun 1, 2024, 00:00

  • RWD27 Creation of a Data Quality Framework for a United States Electronic Medical Record-Based Registry for Individuals with Spinal Muscular Atrophy

    Jun 1, 2024, 00:00

  • EPH175 Assessment of Streptococcus Pneumoniae as Cause of Acute Otitis Media in Young Children in Colombia: A Prospective Study

    Jun 1, 2024, 00:00

  • MSR48 Utilization of High-Dimensional Propensity Score and Targeted Maximum Likelihood Estimation with Machine Learning to Improve Causal Effect Estimation in Patients with Nonvalvular Atrial Fibrillation and Hypertension

    Jun 1, 2024, 00:00

  • HTA7 Access to Pan-Tumor Therapies in Oncology – Do US Patients Have an Advantage?

    Jun 1, 2024, 00:00

  • PCR251 A Conceptual Disease Model for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer (aGC/GEJC): Results From a Targeted Literature Review and Patient Interviews

    Jun 1, 2024, 00:00

  • CO33 Risk Factors for Increased Initial Hospital Length of Stay and 30-Day Readmissions in Patients with Relapsed/Refractory Large B-Cell Lymphoma Treated with Chimeric Antigen Receptor T-Cell Therapy at an Academic Cancer Center

    Jun 1, 2024, 00:00

  • Market Access on Availability and Use of Drugs

    Jun 1, 2024, 00:00

  • EE273 Impact of Mental Health Screening Access on Incremental Cost Estimates Among Patients with Postpartum Depression

    Jun 1, 2024, 00:00

  • PCR95 Are Patient-Reported Outcomes of Advanced Therapies Adequately Measured in the Real-World Settings in Ulcerative Colitis?

    Jun 1, 2024, 00:00

  • MT17 Patient Characteristics Associated with Intentions to Use a Blood Pressure Telemonitoring Device Among Adults with Hypertension in the United States

    Jun 1, 2024, 00:00

  • PCR25 New Zealanders’ Preferences for Community Pharmacies: A Discrete Choice Experiment

    Jun 1, 2024, 00:00

  • CO177 The Effect of Newly Approved Obesity Medications on Cardiovascular Complications

    Jun 1, 2024, 00:00

  • HSD7 Territorial Inequalities in the Number of Cases Related to Benign Gynecological Disorders in Hungary

    Jun 1, 2024, 00:00

  • EE280 Price Trends and Analysis of Targeted Immunomodulatory (TIM) Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Therapy

    Jun 1, 2024, 00:00

  • PCR183 Prevalence of Orthorexia Nervosa Among People on a Plant-Based Diet

    Jun 1, 2024, 00:00

  • HSD98 Benefits and Barriers to Same-Day Long-Acting Reversible Contraceptive Insertion: Evidence and Its Implications from US Settings

    Jun 1, 2024, 00:00

  • PCR10 Psychometric Evaluation and Estimation of Meaningful Change Thresholds of Patient-Reported Outcome Measures in Chronic Inducible Cold Urticaria

    Jun 1, 2024, 00:00

  • EPH234 Real-World Clinical Characteristics and Disease Management of Immunoglobulin a Nephropathy Patients Across the United States

    Jun 1, 2024, 00:00

  • HSD3 Implications of Non-Medical Switching in Medicare Part D: An Updated Review of the Literature

    Jun 1, 2024, 00:00

  • PCR71 Assessing Adherence to SGLT2 Inhibitor Add-on to Metformin Therapy in Chinese T2DM Patients: A Real-World Retrospective Cohort Study

    Jun 1, 2024, 00:00

  • CO4 The Burden of Illness of Treatment-Induced Vasomotor Symptoms in Patients With Breast Cancer: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • PCR242 Electronic Collection of Patient-Reported Outcome Measures in Dermatology Trials

    Jun 1, 2024, 00:00

  • CO71 Characterization of Physician-Reported Outcomes of People with HIV Switching Treatment: Findings from a Real-World Survey in the United States

    Jun 1, 2024, 00:00

  • MSR13 What Most Concerns Patients about the Impact of Diabetes and Its Treatment on Their Ability to Drive?

    Jun 1, 2024, 00:00

  • MSR8 Validating the Time-Use Algorithm To Estimate Productivity Loss in Persons With Multiple Sclerosis

    Jun 1, 2024, 00:00

  • CO149 Comparative Examination of Performance Metrics in Football and Handball Players within Controlled Laboratory Environments

    Jun 1, 2024, 00:00

  • EE264 Cost-Effectiveness of GLP-1 Medications in Non-Diabetic Obesity Population

    Jun 1, 2024, 00:00

  • OP15 Correlation between Quality of Care and Financial Risk Indicators in Public Hospitals

    Jun 1, 2024, 00:00

  • CO6 Clinical Characterization of Patients with Wilson Disease (WD) Using Performance and Qulaitative Measures

    Jun 1, 2024, 00:00

  • EE349 Cost-Effectiveness of First-Line Treatment With Pembrolizumab for Unresectable or Metastatic MSI-H/dMMR Colorectal Cancer (CRC) in the United States Based on 5-Year Follow-up Data

    Jun 1, 2024, 00:00

  • EPH27 The Efficacy of Interventions Utilized in Communicating Risk Information to Improve Behavioral Outcomes Among Individuals Who Are Genetically Predisposed of Type 2 Diabetes: A Systematic Review

    Jun 1, 2024, 00:00

  • RWD98 Real-World Management of Prurigo Nodularis: Epidemiological and Comorbidity Data in China

    Jun 1, 2024, 00:00

  • MT18 Public Perspectives on Emerging Multi-Cancer Early Detection (MCED) Tests: A Qualitative Study

    Jun 1, 2024, 00:00

  • HTA5 Examining the Impact of Eams on NICE Recommendations over the Past Four Years

    Jun 1, 2024, 00:00

  • EE20 Cost Saving Analysis of Implementing Subcutaneous Formulation of Atezolizumab in a Danish Context (CS-ASSIST)

    Jun 1, 2024, 00:00

  • EE348 Optimizing Economic Modelling Approaches in Health Disparities Research: Essential Insights

    Jun 1, 2024, 00:00

  • EE451 Advancing Economic Evaluation Models in Colorectal Cancer Screening: A Comprehensive Methodological Review

    Jun 1, 2024, 00:00

  • EE90 Diagnostic Yield and Downstream Lung Cancer Treatment Revenue From Shape-Sensing Robotic-Assisted Bronchoscopy Compared to Transthoracic Needle Aspiration Biopsy

    Jun 1, 2024, 00:00

  • PCR60 Assessment of Quality of Life in Type II Diabetic Patients

    Jun 1, 2024, 00:00

  • EE116 Budget Impact Model Framework of Positron Emission Tomography Compared to Single Photon Emission Computed Tomography Myocardial Perfusion Imaging for Coronary Artery Disease Diagnosis

    Jun 1, 2024, 00:00

  • EE12 Hypertension-Associated Medical Expenditures Among Privately Insured US Individuals Aged 18 to 64 Years in 2021

    Jun 1, 2024, 00:00

  • SA16 Estimating Infant Date of Birth in Administrative Claims Databases: A Comparison of Exact Date of Birth and Date of Birth Proxies

    Jun 1, 2024, 00:00

  • EE147 Healthcare Resource Utilization of Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF): A Retrospective Claims Analysis

    Jun 1, 2024, 00:00

  • RWD47 Epidemiology of Epidermolysis Bullosa in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • PCR241 Behavioral Economics-Based Financial and Social Incentives for Weight Loss in Newly Diagnosed Type 2 Diabetes: A Randomized Control Trial

    Jun 1, 2024, 00:00

  • EE244 Estimating Treatment Cost Savings of Gender-Neutral Nonavalent HPV Vaccination in Mexico

    Jun 1, 2024, 00:00

  • EE477 Reductions in Real-World Healthcare Resource Utilization Among United States Hereditary Angioedema (HAE) Patients Following Berotralstat Initiation

    Jun 1, 2024, 00:00

  • PCR176 Preferences for a Combination Influenza and COVID-19 Vaccine: Results from a Threshold Technique Study with Consumers in the United Kingdom

    Jun 1, 2024, 00:00

  • RWD127 Combining Patients’ Perspectives and Treatment/ Healthcare Resource Utilization in Chronic Lymphocytic Leukemia Using a Novel Real-World Patient-Centered Database

    Jun 1, 2024, 00:00

  • EE189 A Budget Impact Analysis of Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes Being Treated with Standard of Care in Tertiary Hospital, Riyadh, Saudi Arabia

    Jun 1, 2024, 00:00

  • HSD63 Trends of Outpatient Medication Adherence Among Patients with Type 2 Diabetes in China

    Jun 1, 2024, 00:00

  • EPH154 Impact of COVID-19 Response on Primary Care Utilization

    Jun 1, 2024, 00:00

  • MT22 Mapping Definitions of Patient-Facing Digital Health Intervention in Published Frameworks Against the PICOTS-ComTeC Minimum Information Framework

    Jun 1, 2024, 00:00

  • HSD2 Switching From Anti-VEGF to Corticosteroid Implant Therapy in Diabetic Macular Edema Patients

    Jun 1, 2024, 00:00

  • MSR75 Guidance or Misdirection? Unpacking the Role of Feedback in Health Preference Assessments

    Jun 1, 2024, 00:00

  • EE465 Modeling the Effects of Improving Varicella Vaccination Coverage Rates on Clinical and Economic Outcomes in Peru Over a 10-Year Time-Horizon

    Jun 1, 2024, 00:00

  • MT41 Outcomes and Costs Associated With Cervical Spinal Fusion Surgery

    Jun 1, 2024, 00:00

  • EPH55 An Updated View on the Initial Opioid Prescription Characteristics and Pain Etiologies That Influence Long-Term Opioid Use Among Opioid Naïve Patients

    Jun 1, 2024, 00:00

  • EE26 Economic Burden of Acquired Hemophilia- A Systematic Literature Review

    Jun 1, 2024, 00:00

  • EPH140 Comparative Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular Weight Heparins in Cancer Associated Thrombosis

    Jun 1, 2024, 00:00

  • EE246 Consideration of the Cost of Adverse Events for Oncology Treatment: A Review of Cost-Effectiveness Evaluations in Japan

    Jun 1, 2024, 00:00

  • PCR130 Comparison of the Quality of Life and Socio-Demographic Characteristics of Women with Physical Disabilities

    Jun 1, 2024, 00:00

  • SA1 Methods for Incorporating Non-Randomized Evidence From Single-Arm Trials Into Network Meta-Analysis (NMA): A Case Study in Recurrent/Metastatic Head and Neck Cancer (R/M-HNSCC)

    Jun 1, 2024, 00:00

  • HTA56 ICER Vs NICE – What Are Your Key Considerations for Health Technology Assessments for Rare Disease Therapies? Insights from a Review of Completed Assessments (2017-PRESENT)

    Jun 1, 2024, 00:00

  • RWD181 Healthcare Costs Associated With Newly Diagnosed Type 1 Diabetes in Children With Commercial Health Plan or Medicaid Coverage in US Clinical Practice

    Jun 1, 2024, 00:00

  • EE276 Understanding Trends in Launch Prices across Canada, EU4, UK and the US for High-Revenue Drugs

    Jun 1, 2024, 00:00

  • RWD42 Epidemiology, Healthcare Resource Utilization, and Costs of Ulcerative Colitis and Crohn's Disease Patients in Taiwan: A National Health Insurance Research Database (NHIRD) Study

    Jun 1, 2024, 00:00

  • EE59 Advancing Value of Information Methods: Does Conducting Further Research Directly Translate Into Changes in Clinical Practice, or Do Implementation Rates of Interventions Depend on the Levels and Types of Information Generated?

    Jun 1, 2024, 00:00

  • P47 GPT: The Next Frontier in Health Economic Modeling?

    Jun 1, 2024, 00:00

  • EPH126 A Systematic Review of the Application of Health Behavioral Theories in Drug Disposal and Reuse

    Jun 1, 2024, 00:00

  • PCR195 Assessing Time Trade-Off Utilities in Health States of Chronic Rhinosinusitis with Nasal Polyps: A Pilot Study in Brazil

    Jun 1, 2024, 00:00

  • SA8 Methodological Approaches to Compare Treatment Options for Chronic Hepatitis D: An Early Network Meta-Analysis

    Jun 1, 2024, 00:00

  • PCR163 Comparing Compliance By Race and Ethnicity for Schizophrenia Patients on Oral or Long-Acting Injectable Antipsychotics

    Jun 1, 2024, 00:00

  • RWD188 Healthcare Cost and Healthcare Resource Utilization (HCRU) Among First-Line (1L) Treated Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC): Analysis of Seer-Medicare Linked Claims in the US

    Jun 1, 2024, 00:00

  • PCR107 Health-Related Quality of Life and Utility Values Among Patients With Anxiety and/or Depression in a Low-Income Tertiary Care Setting: A Cross-Sectional Analysis

    Jun 1, 2024, 00:00

  • RWD161 Therapeutic Drug Monitoring (TDM) of Infliximab Is Associated with Lower Biologic Switch Expenditures Compared to No-TDM Cohort of IBD Patients Based on 12 to 48-Month Real-World Outcomes from a US Community GI Practice

    Jun 1, 2024, 00:00

  • MT33 Study Design Considerations for Digital Assessments in Parkinson’s Disease Clinical Trials

    Jun 1, 2024, 00:00

  • PCR193 Estimating Health State Utilities from a Longitudinal SMA Cohort

    Jun 1, 2024, 00:00

  • EPH156 Multimorbidity and Its Associations with Adverse Cardiovascular Events and Healthcare Costs Among Patients with Atherosclerotic Cardiovascular Disease: A Real-World Evidence Study

    Jun 1, 2024, 00:00

  • MT45 Analytical Performance, Quality of Life and Costs Related to Allergy Testing: Results from Two Systematic Literature Reviews

    Jun 1, 2024, 00:00

  • CO34 Glucagon-like Peptide-1 (GLP-1) Receptor Agonists - Efficacy, Safety, and Cost-Effectiveness in Obesity Management: A Systematic Review

    Jun 1, 2024, 00:00

  • EE67 Health Economic Evaluation As a Tool for Sustainable Financing of the Unified Health System: The Case of Hemodialysis

    Jun 1, 2024, 00:00

  • RWD184 Impact of Cardiovascular Medications on Non-Traumatic Amputation Rates in Type 2 Diabetes: Insights from a Large-Scale Retrospective Real-World Data Analysis

    Jun 1, 2024, 00:00

  • EE339 The Biosimilars’ Economic Evaluation in Contrast With Judicializations’ Economic Impacts of the Pharmaceutical Assistance in Brazil

    Jun 1, 2024, 00:00

  • PCR86 Depression Severity Among Pregnant Patients By Antidepressant Use during Pregnancy

    Jun 1, 2024, 00:00

  • RWD13 Epidemiology of Acute Cholecystitis in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • HTA51 Machine Learning Approaches to Reduce Economic Impact of Effective Interventions

    Jun 1, 2024, 00:00

  • EE422 “This Isn’t a Life”: An Analysis of EQ-5D in a Cohort of Individuals with Long COVID Symptoms

    Jun 1, 2024, 00:00

  • EE494 A Budget Impact Analysis of Newer Pneumococcal Conjugate Vaccine Use in All US Adults Aged 50-64 Years Old Compared to Current Recommendations from US Payer Perspective

    Jun 1, 2024, 00:00

  • EE330 Analysis of Public Expenditure of Pharmaceutical Utilization of Female Infertility in Hungary between 2015-2022

    Jun 1, 2024, 00:00

  • EE287 Annual Treatment Cost of Biologic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis

    Jun 1, 2024, 00:00

  • EE114 A Systematic Review of Cost-Effectiveness Analyses of Gene Therapy Treatments for Hemophilia Type A and B

    Jun 1, 2024, 00:00

  • RWD17 Evaluating the Use of Antipsychotic Drug and Incidence of Stroke Among Patients With Dementia in the USA

    Jun 1, 2024, 00:00

  • EE96 An “R-Shiny” Tool for Estimating Transition Probabilities From Various Published Literature for Health Economic Models

    Jun 1, 2024, 00:00

  • EPH144 Exploring the Effectiveness and Engagement of Local Communities in Maternity Care Models for Women with Refugee and Migrant Backgrounds and Its Impact on Enhancing Perinatal Health Outcomes: A Comprehensive Systematic Review

    Jun 1, 2024, 00:00

  • HPR90 Equity Effects of Public Health Insurance on Hypertension in Peru: Insights from a Panel Analysis of the Peruvian Demographic and Health Survey 2013-2019

    Jun 1, 2024, 00:00

  • Real-World Data Information Systems

    Jun 1, 2024, 00:00

  • Epidemiology Public Health

    Jun 1, 2024, 00:00

  • CO15 The Hungarian Nurses Knowledge about Palliative Care

    Jun 1, 2024, 00:00

  • CO119 Indirect Treatment Comparison and Cost-Minimization Analysis between Riociguat and Selexipag to WHO Functional Class III Pulmonary Arterial Hipertension (PAH) Patients

    Jun 1, 2024, 00:00

  • EE346 Expanding Cost-Effectiveness Analysis to Demonstrate Population-Level Treatment Impact on Patients and Society

    Jun 1, 2024, 00:00

  • HSD8 Homologous Recombination Repair Testing Patterns and Barriers in Metastatic Hormone-Sensitive and Metastatic Castration-Resistant Prostate Cancer across Europe: A Real-World Survey

    Jun 1, 2024, 00:00

  • MT7 Measures of ‘Life-Sustaining Medical-Technology’ for Caregivers of Children with Medical Complexity (CO-CMC)

    Jun 1, 2024, 00:00

  • EE313 Economic Impact of Cancer Related to Human Papilloma Virus in Ecuador

    Jun 1, 2024, 00:00

  • EE402 Comparing the Expenditure and Health-Related Quality of Life between SGLT2 Inhibitors and GLP-1 Agonists

    Jun 1, 2024, 00:00

  • CO92 Comparative Effectiveness of Second-Line Immune Targeted Treatments in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Network Meta-Analysis

    Jun 1, 2024, 00:00

  • PCR169 Drivers of Depression and Anxiety in US Non-Segmental Vitiligo Patients

    Jun 1, 2024, 00:00

  • MSR11 Can We Predict the Impact of the Differential Sensitivity of Health-Related Quality of Life (HRQoL) Instruments on the Valuation of Health State Changes?

    Jun 1, 2024, 00:00

  • CO47 A Novel Approach to Estimating the Risk of Harm Due to Drug-Drug Interactions: An Exemplary Model With Common Mediations That Interact With Oral Anticoagulants

    Jun 1, 2024, 00:00

  • EE68 A UK Cost-Utility Analysis of Ferric Carboxymaltose Versus Ferric Derisomaltose in Patients with Iron Deficiency Anemia and Inflammatory Bowel Disease: Incorporation of Fracture Data

    Jun 1, 2024, 00:00

  • EE131 Cost Savings Associated With Use of 3D Heads-up Display (3D-HUD) in Macular Hole Surgeries: An Academic Hospital Perspective

    Jun 1, 2024, 00:00

  • RWD139 Enhancing Public Health Through Timely Detection: Assessing the Value of Real-World Evidence With a Cardiovascular Defibrillator Leads Case Study

    Jun 1, 2024, 00:00

  • PCR210 Impact of Advanced/Metastatic Non–Small Cell Lung Cancer (A/MNSCLC) on Patients in the US and UK: Survey Results

    Jun 1, 2024, 00:00

  • HTA10 Unveiling the Impact of Spironolactone in Women With PCOS: Beyond Its Anti-Androgen Properties - Insights From a Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • PCR80 Make Her Voice Count: Understanding the Use of Patient-Reported Outcomes in Contraceptive Trials

    Jun 1, 2024, 00:00

  • EE407 Treatment Patterns and Healthcare Resource Utilization in Ruxolitinib-Treated Patients with Myelofibrosis with and without Anemia: A Real-World Analysis

    Jun 1, 2024, 00:00

  • EE453 Research and Clinical Delivery Costs of a Mobile Health Approach for Hypertension Management in Uncontrolled Hypertensive African Americans: A Cost Analysis

    Jun 1, 2024, 00:00

  • P36 Unsupported Policy Information? The Institute for Clinical and Economic Review's Unsupported Price Increase Reports

    Jun 1, 2024, 00:00

  • HPR118 Are We Closing the Gap? A Review of Health Equity Focused Interventions Along the Liver Cancer Care Cascade in the US

    Jun 1, 2024, 00:00

  • SA64 One-Step Parametric Network Meta-Analysis Models Using the Exact Likelihood That Allow for Time-Varying Treatment Effects

    Jun 1, 2024, 00:00

  • CO23 Predicting Moderate-to-Severe Plaque Psoriasis From Prescription and Procedure Electronic Health Record Data

    Jun 1, 2024, 00:00

  • EE360 Association Between Public Health Partnership and Telehealth Infrastructure and Medicare Cost and Disparities Among Patients With Depression

    Jun 1, 2024, 00:00

  • PCR129 Indirect Effects of Music Therapy for Aphasia

    Jun 1, 2024, 00:00

  • HPR26 Reimbursement of Medical Devices for Home Care: Worldwide Scenario, Challenges and Proposed Solutions

    Jun 1, 2024, 00:00

  • PCR263 Health Utility Decrement of Treatment-Related Attributes for Type 2 Diabetes Patients in China

    Jun 1, 2024, 00:00

  • EE512 Fluticasone Furoate/Umeclidinium/Vilanterol Vs Open Triple Therapy for Treating Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD) from a Brazilian Public Healthcare Perspective: A Budget Impact Analysis

    Jun 1, 2024, 00:00

  • EE347 JAV-RARAS: Preliminary Results of Measuring Adherence to the Phenylketonuria Treatment Protocol in Brazil

    Jun 1, 2024, 00:00

  • EE508 Cost-Effectiveness Analysis of Pembrolizumab for Advanced Colorectal Cancer with MSI-High or dMMR in Japan

    Jun 1, 2024, 00:00

  • EPH162 Characterizing Antimicrobial Resistance Post-Hospitalization: A Retrospective Analysis Using Administrative Claims Data

    Jun 1, 2024, 00:00

  • EPH37 Determinants of COVID-19 Vaccine Acceptance Among Nigerian Adults

    Jun 1, 2024, 00:00

  • CO22 Health-Related Quality of Life from a Phase 4 Global Clinical Study to Evaluate Discontinuation and Rechallenge of Pexidartinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) Previously Treated with Pexidartinib

    Jun 1, 2024, 00:00

  • EPH116 Factors Influencing the Use of Second-Generation Antipsychotics in Patients With Autism Spectrum Disorders

    Jun 1, 2024, 00:00

  • EE397 Health and Budget Impact of Liquid Biopsy (LBx)-Based Comprehensive Genomic Profiling (CGP) in Patients With Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC)

    Jun 1, 2024, 00:00

  • EE498 What Are the Total Costs of Comprehensive Outpatient Management of Carpal Tunnel and Trigger Finger Using Time Driven Activity Based Costing Models?

    Jun 1, 2024, 00:00

  • HSD33 Contraceptive Use Among Female Patients Who Underwent Bariatric Surgery in the U.S. Commercial Insurance Plans

    Jun 1, 2024, 00:00

  • EE37 Lifetime Survival, Societal Costs and Cost-Effectiveness of Nine Options to Treat Alcohol Use Disorder

    Jun 1, 2024, 00:00

  • PT41 Comparative Analysis of Reintervention Rates in Mesh Versus No Mesh Hernia Repair Using Electronic Health Records

    Jun 1, 2024, 00:00

  • EPH25 Maternal Sexually Transmitted Infection Trends and Characteristics in the United States: 2018-2022

    Jun 1, 2024, 00:00

  • PCR116 Knowledge about Osteoporosis and Risk of Consequent Bone Fracture Among the Elderly People

    Jun 1, 2024, 00:00

  • EE270 Cost-Utility Analysis of Add-on Stiripentol Vs Cannabidiol and Vs Fenfluramine in Dravet Syndrome in the USA

    Jun 1, 2024, 00:00

  • MSR74 The Effect of Applying a Demand Forecasting Model to Assess the Accuracy of Inventory Management in a Specialty Pharmacy

    Jun 1, 2024, 00:00

  • A Methodological Study to Compare Alternative Modes of Administration With Value EQ-5D Using Preference-Elicitation Techniques

    Jun 1, 2024, 00:00

  • EE524 Economic Evaluation of Pronase Granules for Gastric Cancer Screening in High-Risk Population in China

    Jun 1, 2024, 00:00

  • CO210 An Updated Systematic Review and Network Meta-Analysis on Risks of Respiratory Tract Infections with Biologic and Targeted Synthetic Antirheumatic Agents in Psoriatic Arthritis

    Jun 1, 2024, 00:00

  • MT16 What Is the Medical Technology HTA Process in Japan?

    Jun 1, 2024, 00:00

  • EE455 Cost-Effectiveness Analysis of Elacestrant in ER+/HER2- Advanced Breast Cancer Patient from US Payer Perspective

    Jun 1, 2024, 00:00

  • EPH28 Public Health Impact of Switching From a 13-Valent to a 15-Valent Pneumococcal Conjugate Vaccine in the Chilean National Immunization Program

    Jun 1, 2024, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9 (current)
  • 10
  • »